Back
Trevi Therapeutics Stock Price Chart

The EXACT DAY Certain Stocks Soar - Year After Year
Find out now - completely free of charge.
Buy
55
TRVI
Trevi Therapeutics
Last Price:
$6.58
Seasonality Move:
7.34%
7 Day Trial
ALL ACCESS PASS
$
7

Here's the Best Day to Buy Nvidia
Click here to see the green days for 5 major stocks today.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRVI is experiencing slight buying pressure.
Trevi Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.23 | Sell |
20-day SMA: | 6.37 | Sell |
50-day SMA: | 6.29 | Sell |
200-day SMA: | 4.3 | Buy |
8-day EMA: | 6.25 | Sell |
20-day EMA: | 6.32 | Sell |
50-day EMA: | 6.12 | Sell |
200-day EMA: | 4.69 | Buy |
Trevi Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 41.89 | Sell |
Chaikin Money Flow: | 1453474 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.18 - 6.74) | Sell |
Bollinger Bands (100): | (4.29 - 6.55) | Buy |
Trevi Therapeutics Technical Analysis
May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Trevi Therapeutics Stock
Is Trevi Therapeutics Stock a Buy?
-
Trevi Therapeutics share price is 5.95 while TRVI 8-day simple moving average is 6.23, which is a Sell signal.
-
The stock price of TRVI is 5.95 while Trevi Therapeutics 20-day SMA is 6.37, which makes it a Sell.
-
Trevi Therapeutics 50-day simple moving average is 6.29 while TRVI share price is 5.95, making it a Sell technically.
-
TRVI stock price is 5.95 and Trevi Therapeutics 200-day simple moving average is 4.30, creating a Buy signal.
TRVI Technical Analysis vs Fundamental Analysis
Buy
55
Trevi Therapeutics (TRVI)
is a Buy
Is Trevi Therapeutics a Buy or a Sell?
-
Trevi Therapeutics stock is rated a BuyThe current Trevi Therapeutics [TRVI] share price is $5.95. The Score for TRVI is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Trevi Therapeutics Stock Info
Market Cap:
605.4M
Price in USD:
5.95
Share Volume:
4.5M
Trevi Therapeutics 52-Week Range
52-Week High:
7.48
52-Week Low:
2.30
Buy
55
Trevi Therapeutics (TRVI)
is a Buy
Trevi Therapeutics Share Price Forecast
-
What is the Trevi Therapeutics stock price today?The Trevi Therapeutics stock price is 5.95 USD today.
-
Will TRVI stock go up or go down?Trevi Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Trevi Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Trevi Therapeutics is not overvalued.
Is Trevi Therapeutics Stock a Buy?
-
Trevi Therapeutics share price is 5.95 while TRVI 8-day exponential moving average is 6.25, which is a Sell signal.
-
The stock price of TRVI is 5.95 while Trevi Therapeutics 20-day EMA is 6.32, which makes it a Sell.
-
Trevi Therapeutics 50-day exponential moving average is 6.12 while TRVI share price is 5.95, making it a Sell technically.
-
TRVI stock price is 5.95 and Trevi Therapeutics 200-day simple moving average is 4.69, creating a Buy signal.
Fundamental Analysis of Trevi Therapeutics
Is Trevi Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and a decrease next year of $0.06 per share.
Technical Analysis of Trevi Therapeutics
Should I short Trevi Therapeutics stock?
-
TRVI Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Trevi Therapeutics is a Sell
-
Trevi Therapeutics Relative Strength Index (RSI) is 41.89, which suggest Trevi Therapeutics is oversold
-
The Bollinger Bands (25) for Trevi Therapeutics is (6.18 - 6.74), which suggest Trevi Therapeutics is a Buy
-
The Bollinger Bands (100) for Trevi Therapeutics is (4.29 - 6.55), which suggest Trevi Therapeutics is a Buy
* Trevi Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.